A Madison stem cell company plans to manufacture specialized brain cells that it says could help researchers create a path toward better drugs to treat Alzheimer’s and other neurological diseases.

Fujifilm Cellular Dynamics Inc. has signed an agreement with the University of California-Irvine for an exclusive license to a patent for creating microglia cells, a type of brain cell that plays a critical role in preserving the function of the brain.

The technology is “groundbreaking,” the Madison company said.

“For years and years, researchers have relied on animal models, which do not sufficiently mimic human disease,” said Seimi Satake, chairman and CEO of Fujifilm Cellular Dynamics Inc. (FCDI).

Read the full story here.